Chronic active Epstein-Barr virus disease

From IDWiki
Revision as of 00:43, 16 October 2020 by Aidan (talk | contribs) (Created page with "== Background == * Life-threatening infection with Epstein-Barr virus involving NK and T cells === Pathophysiology === * EBV infection involving B, T, or NK cells ===...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

Pathophysiology

  • EBV infection involving B, T, or NK cells

Epidemiology

  • Most cases reported in people of Asian and North American Indigenous descent
  • Most common in Japan

Clinical Manifestations

Management

References

  1. ^  Hiroshi Kimura, Yo Hoshino, Hirokazu Kanegane, Ikuya Tsuge, Takayuki Okamura, Keisei Kawa, Tsuneo Morishima. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98(2):280-286. doi:10.1182/blood.v98.2.280.
  2. ^  Jeffrey I. Cohen, Elaine S. Jaffe, Janet K. Dale, Stefania Pittaluga, Helen E. Heslop, Cliona M. Rooney, Stephen Gottschalk, Catherine M. Bollard, V. Koneti Rao, Adriana Marques, Peter D. Burbelo, Siu-Ping Turk, Rachael Fulton, Alan S. Wayne, Richard F. Little, Mitchell S. Cairo, Nader K. El-Mallawany, Daniel Fowler, Claude Sportes, Michael R. Bishop, Wyndham Wilson, Stephen E. Straus. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011;117(22):5835-5849. doi:10.1182/blood-2010-11-316745.
  3. ^  Motohiko Okano, Keisei Kawa, Hiroshi Kimura, Akihiro Yachie, Hiroshi Wakiguchi, Akihiko Maeda, Shosuke Imai, Shouichi Ohga, Hirokazu Kanegane, Shigeru Tsuchiya, Tomohiro Morio, Masaaki Mori, Shumpei Yokota, Shinsaku Imashuku. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. American Journal of Hematology. 2005;80(1):64-69. doi:10.1002/ajh.20398.